JAK2 and acute lymphoblastic leukemia: They reported that JAK2 mutations and rearrangements are present in ~3.5% of all B-ALL cases but in nearly 19% of DS-ALL cases, confirming their enrichment in this subgroup and association with poor prognosis [72].